Hall PS, Swinson D, Waters JS, et al. Optimizing chemotherapy for frail and elderly patients (pts) with advanced gastroesophageal cancer (aGOAC): The GO2 phase III trial. ASCO Annual Meeting 2019, abstract 4006.
MUC16-mutatie geassocieerd met betere overleving bij maagkanker
aug 2018 | Immuuntherapie, Maag-darm-leveroncologie